Circulating monotypic B‐cells in multiple myeloma: association with lambda paraproteins
- 1 June 1989
- journal article
- research article
- Published by Wiley in British Journal of Haematology
- Vol. 72 (2) , 167-172
- https://doi.org/10.1111/j.1365-2141.1989.tb07678.x
Abstract
The peripheral blood and bone marrow mononuclear cell immunophenotype wa s investigated in a series of 41 patients with plasma cell dyscrasias (29 with multiple myeloma and 12 with monoclonal gammopathy of undetermined significance (MGUS) or solitary plasmacytoma). A statistically significant relationship between the presence of monotypic B-cells (MBC) in the peripheral blood and the paraprotein light chain isotype was found in the myeloma patients (P = 0.0025). MBCs were documented in 71% of patients with lambda paraproteins, compared with only 13% of patients with kappa paraproteins. The difference in MBC was independent of disease stage as well as of individual prognosticators such as haemoglobin, renal function, paraprotein size and beta-2-microglobulin, although lambda producers had significantly higher calcium levels than patients with kappa paraproteins (P = 0.03). A similar trend was also noted for MBC to be found more commonly in patients with lambda producing MGUS and solitary plasmacytoma. This phenomenon may account for the worse prognosis in patients with lambda paraproteins. In our hands, immunophenotypic detection of peripheral blood involvement in plasma cell dyscrasias is more sensitive than investigation of karyotype or immunoglobulin gene rearrangements.This publication has 30 references indexed in Scilit:
- Detection of Monoclonal B Lymphocytes in Multiple Myeloma by Immunofluorescence Tests of Surface ImmunoglobulinsScandinavian Journal of Haematology, 2009
- Serum beta 2 microglobulin in multiple myeloma. A critical reviewEuropean Journal of Cancer and Clinical Oncology, 1987
- DIAGNOSTIC USE OF IMMUNOGLOBULIN AND T‐CELL RECEPTOR GENE REARRANGEMENTS IN LYMPHOPROLIFERATIVE DISEASEAustralian and New Zealand Journal of Medicine, 1987
- Blood clonal B cell excess at diagnosis in multiple myeloma: Relation to prognosisEuropean Journal of Haematology, 1987
- IMMUNOREGULATION AND PROGNOSIS IN MYELOMAThe Lancet, 1987
- Quantitation of the monoclonal plasma cell component in bone marrow from patients with serum paraproteinemia and nondiagnostic marrow morphologyAmerican Journal of Hematology, 1986
- Primary amyloidosis associated with multiple myeloma. Predictors of successful therapyThe American Journal of Medicine, 1986
- Identification of malignant plasma cell precursors in the bone marrow of multiple myeloma.Journal of Clinical Investigation, 1985
- Labeling deoxyribonucleic acid to high specific activity in vitro by nick translation with DNA polymerase IJournal of Molecular Biology, 1977
- Myeloma Proteins and the Clinical Response to Melphalan TherapyScience, 1965